Literature DB >> 21280010

DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen.

Nirit Mor-Vaknin1, Ferdinand Kappes, Amalie E Dick, Maureen Legendre, Catalina Damoc, Seagal Teitz-Tennenbaum, Roland Kwok, Elisa Ferrando-May, Barbara S Adams, David M Markovitz.   

Abstract

OBJECTIVE: DEK is a nuclear phosphoprotein and autoantigen in a subset of children with juvenile idiopathic arthritis (JIA). Autoantibodies to DEK are also found in a broad spectrum of disorders associated with abnormal immune activation. We previously demonstrated that DEK is secreted by macrophages, is released by apoptotic T cells, and attracts leukocytes. Since DEK has been identified in the synovial fluid (SF) of patients with JIA, this study was undertaken to investigate how DEK protein and/or autoantibodies may contribute to the pathogenesis of JIA.
METHODS: DEK autoantibodies, immune complexes (ICs), and synovial macrophages were purified from the SF of patients with JIA. DEK autoantibodies and ICs were purified by affinity-column chromatography and analyzed by 2-dimensional gel electrophoresis, immunoblotting, and enzyme-linked immunosorbent assay. DEK in supernatants and exosomes was purified by serial centrifugation and immunoprecipitation with magnetic beads, and posttranslational modifications of DEK were identified by nano-liquid chromatography tandem mass spectrometry (nano-LC-MS/MS).
RESULTS: DEK autoantibodies and protein were found in the SF of patients with JIA. Secretion of DEK by synovial macrophages was observed both in a free form and via exosomes. DEK autoantibodies (IgG2) may activate the complement cascade, primarily recognize the C-terminal portion of DEK protein, and exhibit higher affinity for acetylated DEK. Consistent with these observations, DEK underwent acetylation on an unprecedented number of lysine residues, as demonstrated by nano-LC-MS/MS.
CONCLUSION: These results indicate that DEK can contribute directly to joint inflammation in JIA by generating ICs through high-affinity interaction between DEK and DEK autoantibodies, a process enhanced by acetylation of DEK in the inflamed joint.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21280010      PMCID: PMC3117121          DOI: 10.1002/art.30138

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  50 in total

1.  The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions.

Authors:  H Le Hir; E Izaurralde; L E Maquat; M J Moore
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

2.  Protein G ELISA for the detection of circulating immune complexes. An alternative to the solid-phase radioimmunoassay for the monoclonal rheumatoid factor.

Authors:  E Van Hoeyveld; L Willebrods; X Bossuyt
Journal:  Clin Chem Lab Med       Date:  2001-06       Impact factor: 3.694

Review 3.  Posttranslational protein modifications: new flavors in the menu of autoantigens.

Authors:  Hester A Doyle; Mark J Mamula
Journal:  Curr Opin Rheumatol       Date:  2002-05       Impact factor: 5.006

4.  Subcellular localization of the human proto-oncogene protein DEK.

Authors:  F Kappes; K Burger; M Baack; F O Fackelmayer; C Gruss
Journal:  J Biol Chem       Date:  2001-05-01       Impact factor: 5.157

5.  Protein phosphatase 2A activates the HIV-2 promoter through enhancer elements that include the pets site.

Authors:  N E Faulkner; J M Hilfinger; D M Markovitz
Journal:  J Biol Chem       Date:  2001-04-24       Impact factor: 5.157

6.  Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.

Authors:  J Wolfers; A Lozier; G Raposo; A Regnault; C Théry; C Masurier; C Flament; S Pouzieux; F Faure; T Tursz; E Angevin; S Amigorena; L Zitvogel
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

7.  Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs.

Authors:  C Grottke; K Mantwill; M Dietel; D Schadendorf; H Lage
Journal:  Int J Cancer       Date:  2000-11-15       Impact factor: 7.396

8.  Evidence for activation of the alternate complement pathway in patients with juvenile rheumatoid arthritis.

Authors:  A Aggarwal; A Bhardwaj; S Alam; R Misra
Journal:  Rheumatology (Oxford)       Date:  2000-02       Impact factor: 7.580

9.  Melanoma proliferation and chemoresistance controlled by the DEK oncogene.

Authors:  Michael S Khodadoust; Monique Verhaegen; Ferdinand Kappes; Erica Riveiro-Falkenbach; Juan C Cigudosa; David S L Kim; Arul M Chinnaiyan; David M Markovitz; María S Soengas
Journal:  Cancer Res       Date:  2009-08-15       Impact factor: 12.701

10.  The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes.

Authors:  T McGarvey; E Rosonina; S McCracken; Q Li; R Arnaout; E Mientjes; J A Nickerson; D Awrey; J Greenblatt; G Grosveld; B J Blencowe
Journal:  J Cell Biol       Date:  2000-07-24       Impact factor: 10.539

View more
  37 in total

1.  Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.

Authors:  Maegan L Capitano; Nirit Mor-Vaknin; Anjan K Saha; Scott Cooper; Maureen Legendre; Haihong Guo; Rafael Contreras-Galindo; Ferdinand Kappes; Maureen A Sartor; Christopher T Lee; Xinxin Huang; David M Markovitz; Hal E Broxmeyer
Journal:  J Clin Invest       Date:  2019-05-20       Impact factor: 14.808

2.  Biological properties of extracellular vesicles and their physiological functions.

Authors:  María Yáñez-Mó; Pia R-M Siljander; Zoraida Andreu; Apolonija Bedina Zavec; Francesc E Borràs; Edit I Buzas; Krisztina Buzas; Enriqueta Casal; Francesco Cappello; Joana Carvalho; Eva Colás; Anabela Cordeiro-da Silva; Stefano Fais; Juan M Falcon-Perez; Irene M Ghobrial; Bernd Giebel; Mario Gimona; Michael Graner; Ihsan Gursel; Mayda Gursel; Niels H H Heegaard; An Hendrix; Peter Kierulf; Katsutoshi Kokubun; Maja Kosanovic; Veronika Kralj-Iglic; Eva-Maria Krämer-Albers; Saara Laitinen; Cecilia Lässer; Thomas Lener; Erzsébet Ligeti; Aija Linē; Georg Lipps; Alicia Llorente; Jan Lötvall; Mateja Manček-Keber; Antonio Marcilla; Maria Mittelbrunn; Irina Nazarenko; Esther N M Nolte-'t Hoen; Tuula A Nyman; Lorraine O'Driscoll; Mireia Olivan; Carla Oliveira; Éva Pállinger; Hernando A Del Portillo; Jaume Reventós; Marina Rigau; Eva Rohde; Marei Sammar; Francisco Sánchez-Madrid; N Santarém; Katharina Schallmoser; Marie Stampe Ostenfeld; Willem Stoorvogel; Roman Stukelj; Susanne G Van der Grein; M Helena Vasconcelos; Marca H M Wauben; Olivier De Wever
Journal:  J Extracell Vesicles       Date:  2015-05-14

3.  Intercellular trafficking of the nuclear oncoprotein DEK.

Authors:  Anjan K Saha; Ferdinand Kappes; Amruta Mundade; Anja Deutzmann; David M Rosmarin; Maureen Legendre; Nicolas Chatain; Zeina Al-Obaidi; Barbara S Adams; Hidde L Ploegh; Elisa Ferrando-May; Nirit Mor-Vaknin; David M Markovitz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

4.  DEK regulates hematopoietic stem engraftment and progenitor cell proliferation.

Authors:  Hal E Broxmeyer; Ferdinand Kappes; Nirit Mor-Vaknin; Maureen Legendre; John Kinzfogl; Scott Cooper; Giao Hangoc; David M Markovitz
Journal:  Stem Cells Dev       Date:  2011-10-27       Impact factor: 3.272

Review 5.  Emerging role of extracellular vesicles in inflammatory diseases.

Authors:  Edit I Buzas; Bence György; György Nagy; András Falus; Steffen Gay
Journal:  Nat Rev Rheumatol       Date:  2014-02-18       Impact factor: 20.543

Review 6.  Autoantigenesis: the evolution of protein modifications in autoimmune disease.

Authors:  Hester A Doyle; Mark J Mamula
Journal:  Curr Opin Immunol       Date:  2011-12-29       Impact factor: 7.486

7.  The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity.

Authors:  Ferdinand Kappes; Tanja Waldmann; Veena Mathew; Jindan Yu; Ling Zhang; Michael S Khodadoust; Arul M Chinnaiyan; Karolin Luger; Sylvia Erhardt; Robert Schneider; David M Markovitz
Journal:  Genes Dev       Date:  2011-04-01       Impact factor: 11.361

8.  Extracellular Vesicles: Evolving Contributors in Autoimmunity.

Authors:  Stergios Katsiougiannis
Journal:  For Immunopathol Dis Therap       Date:  2015

Review 9.  Stacking the DEK: from chromatin topology to cancer stem cells.

Authors:  Lisa M Privette Vinnedge; Ferdinand Kappes; Nicolas Nassar; Susanne I Wells
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

Review 10.  Concise review: role of DEK in stem/progenitor cell biology.

Authors:  Hal E Broxmeyer; Nirit Mor-Vaknin; Ferdinand Kappes; Maureen Legendre; Anjan K Saha; Xuan Ou; Heather O'Leary; Maegan Capitano; Scott Cooper; David M Markovitz
Journal:  Stem Cells       Date:  2013-08       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.